Publications by authors named "S Barbato"

Claim this Profile
A
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.
I Rizzello, I Sacchetti, S Barbato, V Solli, P Stefanoni

Clin Exp Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, S Delimpasi, M Puppi

J Cancer Res Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.
Marco Talarico, Gisella Vischini, Simona Barbato, Roberta Restuccia, Simone Masci

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. 2025, , 1168.
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, Francesca Gay, Pellegrino Musto

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.
Flavia Bigi, Mauro Fiacchini, Roberta Restuccia, Simone Masci, Gaia Mazzocchetti, Simona Barbato

Clin Exp Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis